Agenda of the COMP meeting 18-20 June 2024
Submitted by Anonymous (not verified) on 18 June 2024 - 10:21
Agenda of the COMP meeting 18-20 June 2024
Faster access to clinical trial information in Europe
Submitted by Anonymous (not verified) on 18 June 2024 - 10:12
Faster access to clinical trial information in Europe
Clinical Trial Information System (CTIS) structured data form - Request for information (RFI)
Submitted by Anonymous (not verified) on 18 June 2024 - 10:00
Clinical Trial Information System (CTIS) structured data form - Request for information (RFI)
Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modification
Submitted by Anonymous (not verified) on 18 June 2024 - 10:00
Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modification
Appendix, on disclosure rules, to the functional specifications for the EU portal and EU database to be audited
Submitted by Anonymous (not verified) on 18 June 2024 - 10:00
Appendix, on disclosure rules, to the functional specifications for the EU portal and EU database to be audited
Agenda of the CVMP meeting 18-20 June 2024
Submitted by Anonymous (not verified) on 17 June 2024 - 15:31
Agenda of the CVMP meeting 18-20 June 2024
CTIS newsflash – 14 June 2024
Submitted by Anonymous (not verified) on 17 June 2024 - 15:23
CTIS newsflash – 14 June 2024
Veterinary medicines European public assessment report (EPAR): Lotimax, lotilaner, Status: Authorised
Submitted by Anonymous (not verified) on 17 June 2024 - 15:01
Veterinary medicines European public assessment report (EPAR): Lotimax, lotilaner, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Lexylan, Cefalexin, Status: Authorised
Submitted by Anonymous (not verified) on 17 June 2024 - 14:55
Veterinary medicines European public assessment report (EPAR): Lexylan, Cefalexin, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Trilorale, trilostane, Status: Authorised
Submitted by Anonymous (not verified) on 17 June 2024 - 14:39
Veterinary medicines European public assessment report (EPAR): Trilorale, trilostane, Status: Authorised